Skip to main content
Clinical Trials/NCT03052010
NCT03052010
Completed
Phase 4

Delivery of Integrated PrEP and ART for Couples in Kenya

University of Washington2 sites in 1 country4,898 target enrollmentFebruary 6, 2017

Overview

Phase
Phase 4
Intervention
Integrated PrEP as a bridge to ART HIV-1 prevention strategy
Conditions
HIV-1-infection
Sponsor
University of Washington
Enrollment
4898
Locations
2
Primary Endpoint
Number of HIV-1 infected persons whose partners are tested for HIV-1 before/after PrEP as a bridge to ART is implemented
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

An implementation project to scale-up delivery of antiretroviral-based HIV-1 prevention methods to Kenyan HIV-1 serodiscordant couples in HIV-1 care centers. Pre-exposure prophylaxis (PrEP) as a bridge to antiretroviral therapy (ART) HIV-1 prevention strategy will be introduced into 24 public HIV-1 care centers in central and western Kenya according to national guidelines using a stepped wedge design, stratified by region.

Detailed Description

PrEP as a bridge to ART strategy will be introduced into 24 Kenyan public HIV-1 care centers according to national guidelines, in staged fashion, stratified by region (a stepped wedge design). Monitoring and evaluation activities will identify implementation barriers and solutions, characterize costs, and provide best practices for further scale-up. A research component will establish prospective open cohorts of couples at each clinic (up to 200) to study how the program is effectively implemented. Follow-up in the cohorts will be for up to 36 months at each care center and will evaluate impact, costs, and facilitators and barriers to implementation at patient, provider and health system levels.

Registry
clinicaltrials.gov
Start Date
February 6, 2017
End Date
April 30, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jared Baeten

Professor, Global Health, Medicine, & Epidemiology

University of Washington

Eligibility Criteria

Inclusion Criteria

  • For HIV-1 uninfected members of the couple
  • Able and willing to provide consent for follow-up in the cohort
  • HIV-1 uninfected based on negative HIV-1 tests, per Kenya national guidelines
  • Not currently using PrEP
  • For HIV-1 infected members of the couple
  • Able and willing to provide consent for follow-up in the cohort
  • HIV-1 infected based on positive HIV-1 tests, per Kenya national guidelines
  • Not currently using ART
  • For both members of the couple - Meet criteria for initiating PrEP as per Kenya national guidelines, including:
  • HIV-1 infected member not currently using ART, on ART \<6 months, or on ART but not virally suppressed based on a viral load test done at the clinic as per Kenya national guidelines or

Exclusion Criteria

  • Otherwise not eligible based on the above inclusion criteria

Arms & Interventions

PrEP for HIV-1 uninfected partners and ART for HIV-1 infected

Integrated PrEP as a bridge to ART HIV-1 prevention strategy

Intervention: Integrated PrEP as a bridge to ART HIV-1 prevention strategy

PrEP for HIV-1 uninfected partners and ART for HIV-1 infected

Integrated PrEP as a bridge to ART HIV-1 prevention strategy

Intervention: PrEP

PrEP for HIV-1 uninfected partners and ART for HIV-1 infected

Integrated PrEP as a bridge to ART HIV-1 prevention strategy

Intervention: ART

Outcomes

Primary Outcomes

Number of HIV-1 infected persons whose partners are tested for HIV-1 before/after PrEP as a bridge to ART is implemented

Time Frame: up to 36 months

PrEP initiation

Time Frame: up to 36 months

Measure the number of HIV-1 uninfected partners initiating PrEP.

PrEP adherence

Time Frame: up to 6 months

Adherence by HIV-1 uninfected partners until their HIV-1 infected partners initiate ART and sustain use for six months. Adherence will be measured by self reported and random dry blood spot for tenofovir levels

HIV-1 uninfected partners staying HIV-1 uninfected.

Time Frame: up to 36 months

ART initiation

Time Frame: up to 36 months

Number of HIV-1 infected partners newly initiating ART

ART adherence

Time Frame: up to 6 months

Adherence measured by plasma RNA viral load. Viral load will be abstract from the HIV-infected partners records.

Facilitators and barriers to implementation of integrated PrEP and ART

Time Frame: up to 36 months

Mixed methods assessment of how integrated PrEP and ART is implemented at the level of provider, health center, and health systems

PrEP delivery operational tools

Time Frame: 24 months

Training manual on deliver of integrated PrEP and ART HIV prevention strategy for couples will be developed.

Cost and cost-effectiveness of the integrated PrEP and ART when delivered in public health clinics.

Time Frame: up to 36 months

Time and motions to define the cost and cost-effectiveness of intervention summarized in terms of HIV infections averted, disability-adjusted life years saved, and incremental cost-effectiveness over routine HIV-1 care

Study Sites (2)

Loading locations...

Similar Trials